KAYA
|
KAYA Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 63.89 | -98.91 | -89.15 | -52.69 | -29.10 |
| CEPS(Rs) | 3.26 | 6.27 | -17.58 | 13.75 | 17.40 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | -106.61 | -174.93 | -81.58 | -2.17 | 41.70 |
| Tax Rate(%) | - | - | - | - | - |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 9.04 | 15.08 | 3.73 | 8.32 | 9.80 |
| EBIT Margin(%) | -0.44 | -32.34 | -19.84 | -14.57 | -6.70 |
| Pre Tax Margin(%) | -15.36 | -45.68 | -30.86 | -20.98 | -13.61 |
| PAT Margin (%) | -15.36 | -45.68 | -30.86 | -20.98 | -13.61 |
| Cash Profit Margin (%) | 1.97 | 3.99 | -6.10 | 5.55 | 8.27 |
| Performance Ratios | |||||
| ROA(%) | -12.54 | -28.17 | -31.81 | -18.64 | -9.58 |
| ROE(%) | - | - | - | -263.21 | -55.98 |
| ROCE(%) | - | - | -121.62 | -53.94 | -18.27 |
| Asset Turnover(x) | 0.82 | 0.62 | 1.03 | 0.89 | 0.70 |
| Sales/Fixed Asset(x) | 0.67 | 0.45 | 0.81 | 0.76 | 0.67 |
| Working Capital/Sales(x) | -2.85 | -1.11 | -3.55 | -3.59 | -2.65 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.49 | 2.23 | 1.24 | 1.32 | 1.48 |
| Receivable days | 5.07 | 6.64 | 3.57 | 4.02 | 5.61 |
| Inventory Days | 45.69 | 51.68 | 27.33 | 30.75 | 42.24 |
| Payable days | 763.48 | 1,305.49 | 1,177.87 | 1,829.08 | 1,518.93 |
| Valuation Parameters | |||||
| PER(x) | 3.65 | - | - | - | - |
| PCE(x) | 71.54 | 50.02 | -14.41 | 25.48 | 17.03 |
| Price/Book(x) | -2.19 | -1.79 | -3.10 | -161.21 | 7.11 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 2.04 | 2.78 | 1.11 | 1.60 | 1.49 |
| EV/Core EBITDA(x) | 12.06 | 16.01 | 22.59 | 13.37 | 9.83 |
| EV/EBIT(x) | -459.80 | -8.58 | -5.60 | -10.98 | -22.27 |
| EV/CE(x) | 95.82 | -11.62 | 10.93 | 6.12 | 1.11 |
| M Cap / Sales | 1.41 | 2.00 | 0.88 | 1.41 | 1.41 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 5.84 | -45.54 | 16.29 | 17.82 | -30.07 |
| Core EBITDA Growth(%) | 3.14 | 91.73 | -52.11 | -7.17 | -35.07 |
| EBIT Growth(%) | 98.55 | 11.23 | -58.39 | -156.16 | -67.36 |
| PAT Growth(%) | 64.40 | 19.38 | -71.08 | -81.66 | 30.86 |
| EPS Growth(%) | 164.59 | -10.95 | -69.19 | -81.09 | 30.15 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | -1.03 | -0.78 | -1.33 | -30.33 | 0.66 |
| Current Ratio(x) | 0.46 | 0.36 | 0.57 | 0.54 | 0.43 |
| Quick Ratio(x) | 0.28 | 0.26 | 0.45 | 0.40 | 0.28 |
| Interest Cover(x) | -0.03 | -2.42 | -1.80 | -2.27 | -0.97 |
| Total Debt/Mcap(x) | 0.47 | 0.43 | 0.43 | 0.19 | 0.09 |
Compare Financial Ratios of peers of KAYA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KAYA | ₹590.9 Cr | 4.2% | 24.1% | -27.3% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹118,495.0 Cr | -3.7% | 2.2% | 32.5% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹104,184.0 Cr | -1.4% | 3.5% | 13.6% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹61,102.5 Cr | 1.7% | 7.3% | 66.9% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹40,588.1 Cr | 1.8% | 0% | 54.4% | Stock Analytics | |
| GLOBAL HEALTH | ₹34,682.1 Cr | -3.6% | 11.4% | 8.1% | Stock Analytics | |
KAYA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KAYA | 4.2% |
24.1% |
-27.3% |
| SENSEX | -0.5% |
-0.3% |
1% |
You may also like the below Video Courses
